questionsmedicales.fr
Métabolisme
Désalkylation
Désalkylation : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Désalkylation
Tests biochimiques
Anomalies hépatiques
Désalkylation
Imagerie médicale
Désalkylation
Enzymes hépatiques
Désalkylation
Symptômes
5
Nausées
Douleurs abdominales
Effets neurologiques
Désalkylation
Éruptions cutanées
Désalkylation
Hépatotoxicité
Désalkylation
Prévention
5
Prévention
Substances chimiques
Contrôles médicaux
Désalkylation
Éducation des patients
Médicaments
Mode de vie
Complications
Professionnels de santé
Interactions médicamenteuses
Traitements
5
Antidotes
Soins de soutien
Antiémétiques
Analgésiques
Prévention
Substances toxiques
Complications
5
Lésions hépatiques
Troubles neurologiques
Maladies chroniques
Cirrhose
Réversibilité
Traitement précoce
Surveillance clinique
Tests de laboratoire
Facteurs de risque
5
Facteurs de risque
Antécédents hépatiques
Habitudes alimentaires
Toxines
Tabagisme
Substances nocives
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Désalkylation : Questions médicales les plus fréquentes",
"headline": "Désalkylation : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Désalkylation : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-28",
"dateModified": "2025-02-22",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Désalkylation"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Métabolisme",
"url": "https://questionsmedicales.fr/mesh/D008660",
"about": {
"@type": "MedicalCondition",
"name": "Métabolisme",
"code": {
"@type": "MedicalCode",
"code": "D008660",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G03"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Déméthylation",
"alternateName": "Demethylation",
"url": "https://questionsmedicales.fr/mesh/D000073398",
"about": {
"@type": "MedicalCondition",
"name": "Déméthylation",
"code": {
"@type": "MedicalCode",
"code": "D000073398",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G03.219.500"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Déméthylation de l'ADN",
"alternateName": "DNA Demethylation",
"url": "https://questionsmedicales.fr/mesh/D000073399",
"about": {
"@type": "MedicalCondition",
"name": "Déméthylation de l'ADN",
"code": {
"@type": "MedicalCode",
"code": "D000073399",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G03.219.500.500"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Désalkylation",
"alternateName": "Dealkylation",
"code": {
"@type": "MedicalCode",
"code": "D003640",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Michael R Baldwin",
"url": "https://questionsmedicales.fr/author/Michael%20R%20Baldwin",
"affiliation": {
"@type": "Organization",
"name": "Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, Michigan 48109-0600."
}
},
{
"@type": "Person",
"name": "Suzanne J Admiraal",
"url": "https://questionsmedicales.fr/author/Suzanne%20J%20Admiraal",
"affiliation": {
"@type": "Organization",
"name": "Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, Michigan 48109-0600."
}
},
{
"@type": "Person",
"name": "Patrick J O'Brien",
"url": "https://questionsmedicales.fr/author/Patrick%20J%20O%27Brien",
"affiliation": {
"@type": "Organization",
"name": "Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, Michigan 48109-0600. Electronic address: pjobrien@umich.edu."
}
},
{
"@type": "Person",
"name": "Yusuke Suzuki",
"url": "https://questionsmedicales.fr/author/Yusuke%20Suzuki",
"affiliation": {
"@type": "Organization",
"name": "Department of Hospital Pharmacy, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, Shizuoka, 431-3192, Japan."
}
},
{
"@type": "Person",
"name": "Takafumi Naito",
"url": "https://questionsmedicales.fr/author/Takafumi%20Naito",
"affiliation": {
"@type": "Organization",
"name": "Department of Hospital Pharmacy, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, Shizuoka, 431-3192, Japan. naitou@shinshu-u.ac.jp."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Levonorgestrel-protected Au",
"datePublished": "2022-07-06",
"url": "https://questionsmedicales.fr/article/35723599",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1039/d2tb00533f"
}
},
{
"@type": "ScholarlyArticle",
"name": "Sorption of levonorgestrel on polyethylene, polystyrene and polypropylene microplastics.",
"datePublished": "2023-05-25",
"url": "https://questionsmedicales.fr/article/37244556",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.chemosphere.2023.139042"
}
},
{
"@type": "ScholarlyArticle",
"name": "Levonorgestrel-Releasing Intrauterine System Utilization in Patients with Developmental Delays.",
"datePublished": "2022-09-08",
"url": "https://questionsmedicales.fr/article/36089116",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jpag.2022.09.003"
}
},
{
"@type": "ScholarlyArticle",
"name": "Compare the Efficacy of Dienogest and the Levonorgestrel Intrauterine System in Women with Adenomyosis.",
"datePublished": "2023-08-18",
"url": "https://questionsmedicales.fr/article/37599165",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.clinthera.2023.07.019"
}
},
{
"@type": "ScholarlyArticle",
"name": "Impact of drug loading on release from levonorgestrel intrauterine systems.",
"datePublished": "2022-12-21",
"url": "https://questionsmedicales.fr/article/36565771",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ijpharm.2022.122532"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Métabolisme",
"item": "https://questionsmedicales.fr/mesh/D008660"
},
{
"@type": "ListItem",
"position": 3,
"name": "Désalkylation",
"item": "https://questionsmedicales.fr/mesh/D003640"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Désalkylation - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Désalkylation",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Désalkylation",
"description": "Comment diagnostiquer une désalkylation ?\nQuels tests sont utilisés pour la désalkylation ?\nQuels signes indiquent une désalkylation ?\nLa désalkylation est-elle détectable par imagerie ?\nQuels marqueurs sont associés à la désalkylation ?",
"url": "https://questionsmedicales.fr/mesh/D003640?mesh_terms=Levonorgestrel#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Désalkylation",
"description": "Quels symptômes sont liés à la désalkylation ?\nLa désalkylation provoque-t-elle des effets neurologiques ?\nY a-t-il des symptômes cutanés associés ?\nLa désalkylation affecte-t-elle le foie ?\nQuels signes de toxicité sont observés ?",
"url": "https://questionsmedicales.fr/mesh/D003640?mesh_terms=Levonorgestrel#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Désalkylation",
"description": "Comment prévenir la désalkylation ?\nLes contrôles médicaux aident-ils à prévenir la désalkylation ?\nL'éducation des patients est-elle importante ?\nLes changements de mode de vie aident-ils ?\nLes professionnels de santé jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D003640?mesh_terms=Levonorgestrel#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Désalkylation",
"description": "Quel traitement pour une désalkylation toxique ?\nLes médicaments peuvent-ils aider à la désalkylation ?\nComment gérer les symptômes de désalkylation ?\nY a-t-il des traitements préventifs ?\nLa désalkylation nécessite-t-elle une hospitalisation ?",
"url": "https://questionsmedicales.fr/mesh/D003640?mesh_terms=Levonorgestrel#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Désalkylation",
"description": "Quelles complications peuvent survenir ?\nLa désalkylation peut-elle entraîner des maladies chroniques ?\nY a-t-il des risques de surdosage ?\nLes complications sont-elles réversibles ?\nComment surveiller les complications ?",
"url": "https://questionsmedicales.fr/mesh/D003640?mesh_terms=Levonorgestrel#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Désalkylation",
"description": "Quels sont les facteurs de risque de désalkylation ?\nL'âge influence-t-il le risque de désalkylation ?\nLes habitudes alimentaires affectent-elles le risque ?\nLe tabagisme est-il un facteur de risque ?\nLes maladies préexistantes influencent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D003640?mesh_terms=Levonorgestrel#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une désalkylation ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests biochimiques et des analyses de sang pour évaluer les métabolites."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour la désalkylation ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de toxicologie et des analyses enzymatiques sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une désalkylation ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes cliniques comme des anomalies hépatiques peuvent indiquer une désalkylation."
}
},
{
"@type": "Question",
"name": "La désalkylation est-elle détectable par imagerie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, la désalkylation est généralement évaluée par des tests biochimiques, pas par imagerie."
}
},
{
"@type": "Question",
"name": "Quels marqueurs sont associés à la désalkylation ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les marqueurs comme les enzymes hépatiques peuvent être augmentés lors de la désalkylation."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à la désalkylation ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure des nausées, des vomissements et des douleurs abdominales."
}
},
{
"@type": "Question",
"name": "La désalkylation provoque-t-elle des effets neurologiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets neurologiques comme des vertiges peuvent survenir en cas de désalkylation."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes cutanés associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des éruptions cutanées peuvent apparaître en raison de réactions aux métabolites de désalkylation."
}
},
{
"@type": "Question",
"name": "La désalkylation affecte-t-elle le foie ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner des anomalies hépatiques et une hépatotoxicité."
}
},
{
"@type": "Question",
"name": "Quels signes de toxicité sont observés ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes de toxicité incluent fatigue, confusion et jaunisse dans les cas graves."
}
},
{
"@type": "Question",
"name": "Comment prévenir la désalkylation ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter l'exposition à des substances chimiques et suivre les prescriptions médicales aide."
}
},
{
"@type": "Question",
"name": "Les contrôles médicaux aident-ils à prévenir la désalkylation ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des contrôles réguliers peuvent détecter des problèmes avant qu'ils ne deviennent graves."
}
},
{
"@type": "Question",
"name": "L'éducation des patients est-elle importante ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, informer les patients sur les risques des médicaments et des toxines est crucial."
}
},
{
"@type": "Question",
"name": "Les changements de mode de vie aident-ils ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Adopter un mode de vie sain peut réduire le risque de désalkylation et de complications."
}
},
{
"@type": "Question",
"name": "Les professionnels de santé jouent-ils un rôle ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les professionnels de santé doivent surveiller les interactions médicamenteuses et les risques."
}
},
{
"@type": "Question",
"name": "Quel traitement pour une désalkylation toxique ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement peut inclure des soins de soutien et des antidotes spécifiques selon le toxique."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider à la désalkylation ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent faciliter le métabolisme et l'élimination des toxines."
}
},
{
"@type": "Question",
"name": "Comment gérer les symptômes de désalkylation ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des symptômes inclut des antiémétiques et des analgésiques pour le confort."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements préventifs ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les substances toxiques et surveiller les médicaments peut prévenir la désalkylation."
}
},
{
"@type": "Question",
"name": "La désalkylation nécessite-t-elle une hospitalisation ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cela dépend de la gravité des symptômes et de l'exposition aux toxines, parfois nécessaire."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des lésions hépatiques, des troubles neurologiques et des réactions allergiques."
}
},
{
"@type": "Question",
"name": "La désalkylation peut-elle entraîner des maladies chroniques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une désalkylation sévère peut contribuer à des maladies chroniques comme la cirrhose."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de surdosage ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un surdosage de substances pouvant subir désalkylation peut être fatal."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement précoce, d'autres non."
}
},
{
"@type": "Question",
"name": "Comment surveiller les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La surveillance clinique et les tests de laboratoire réguliers sont essentiels pour détecter les complications."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de désalkylation ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'exposition à des toxines, l'usage de certains médicaments et des antécédents hépatiques."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de désalkylation ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent avoir un risque accru en raison d'une fonction hépatique diminuée."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires affectent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en toxines ou en médicaments peut augmenter le risque de désalkylation."
}
},
{
"@type": "Question",
"name": "Le tabagisme est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut augmenter le risque de désalkylation en raison de l'exposition à des substances nocives."
}
},
{
"@type": "Question",
"name": "Les maladies préexistantes influencent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme l'hépatite ou la cirrhose augmentent le risque de désalkylation."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 22/02/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, Michigan 48109-0600.
Publications dans "Désalkylation" :
2 publications dans cette catégorie
Affiliations :
Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, Michigan 48109-0600.
Publications dans "Désalkylation" :
2 publications dans cette catégorie
Affiliations :
Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, Michigan 48109-0600. Electronic address: pjobrien@umich.edu.
Publications dans "Désalkylation" :
2 publications dans cette catégorie
Affiliations :
Department of Hospital Pharmacy, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, Shizuoka, 431-3192, Japan.
Publications dans "Désalkylation" :
2 publications dans cette catégorie
Affiliations :
Department of Hospital Pharmacy, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, Shizuoka, 431-3192, Japan. naitou@shinshu-u.ac.jp.
Department of Pharmacy, Shinshu University Hospital, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan. naitou@shinshu-u.ac.jp.
Publications dans "Désalkylation" :
2 publications dans cette catégorie
Affiliations :
Department of Hospital Pharmacy, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, Shizuoka, 431-3192, Japan.
Publications dans "Désalkylation" :
2 publications dans cette catégorie
Affiliations :
Department of Hospital Pharmacy, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, Shizuoka, 431-3192, Japan.
Publications dans "Désalkylation" :
1 publication dans cette catégorie
Affiliations :
Department of Chemistry, Texas A&M University, College Station, Texas 77843, United States.
Publications dans "Désalkylation" :
1 publication dans cette catégorie
Affiliations :
Department of Chemistry, Texas A&M University, College Station, Texas 77843, United States.
Publications dans "Désalkylation" :
1 publication dans cette catégorie
Affiliations :
Department of Chemistry, Texas A&M University, College Station, Texas 77843, United States.
Publications dans "Désalkylation" :
1 publication dans cette catégorie
Affiliations :
Kodikos Laboratories, Institut Cochin, Paris 75014, France.
Publications dans "Désalkylation" :
1 publication dans cette catégorie
Affiliations :
Kodikos Laboratories, Institut Cochin, Paris 75014, France.
Publications dans "Désalkylation" :
1 publication dans cette catégorie
Affiliations :
Department of Chemistry, Texas A&M University, College Station, Texas 77843, United States.
Publications dans "Désalkylation" :
1 publication dans cette catégorie
Affiliations :
Department of Analytical Biochemistry, Groningen Research Institute of Pharmacy, University of Groningen, A Deusinglaan 1, 9713 AV, Groningen, The Netherlands.
Publications dans "Désalkylation" :
1 publication dans cette catégorie
Affiliations :
Department of Chemical Engineering, Engineering and Technology Institute Groningen, University of Groningen, 9747 AG, Groningen, The Netherlands.
Publications dans "Désalkylation" :
1 publication dans cette catégorie
Affiliations :
Department of Drug Design, University of Groningen, A Deusinglaan 1, 9713 AV, Groningen, The Netherlands.
Publications dans "Désalkylation" :
1 publication dans cette catégorie
Affiliations :
Department of Analytical Biochemistry, Groningen Research Institute of Pharmacy, University of Groningen, A Deusinglaan 1, 9713 AV, Groningen, The Netherlands.
Publications dans "Désalkylation" :
1 publication dans cette catégorie
Affiliations :
Department of Analytical Biochemistry, Groningen Research Institute of Pharmacy, University of Groningen, A Deusinglaan 1, 9713 AV, Groningen, The Netherlands.
Publications dans "Désalkylation" :
1 publication dans cette catégorie
Affiliations :
Department of Chemical Engineering, Engineering and Technology Institute Groningen, University of Groningen, 9747 AG, Groningen, The Netherlands.
Publications dans "Désalkylation" :
1 publication dans cette catégorie
Affiliations :
Department of Drug Design, University of Groningen, A Deusinglaan 1, 9713 AV, Groningen, The Netherlands.
Publications dans "Désalkylation" :
Gold nanoclusters exhibit significant potential in antimicrobial applications due to their good stability and desirable biocompatibility in the mammalian cell model. However, most of the previously re...
Sorption studies involving microplastics (MPs) are essential to understand the mechanisms implicated in contaminant retention. In this research, a complete study of the sorption behaviour of a hormona...
Adolescent females with developmental delays (DDs) experience unique physical and emotional challenges related to menstruation. Providers often recommend hormonal medication for menstrual management. ...
We utilized the Pediatric Health Information System to identify females aged 10-25 with DDs who underwent an LNG-IUS insertion between 2011 and 2020. Using a gynecologic procedure and diagnosis codes,...
One thousand five hundred and sixty female patients with DDs underwent LNG-IUS insertion. LNG-IUS insertion under anesthesia was most commonly performed in patients with autism and Down syndrome, and ...
This is the largest analysis of LNG-IUS use in patients with DDs to our knowledge and shows the utilization of LNG-IUS in patients with DDs. We provide descriptive information that providers can use t...
The goal of this study was to examine the efficacy and safety of the levonorgestrel intrauterine system (LNG-IUS) versus dienogest (DNG) in female subjects with symptomatic uterine adenomyosis....
This study enrolled 117 women with symptomatic adenomyosis who visited our hospital from May 1, 2019, to June 30, 2022. Participants were randomized to either the LNG-IUS group (n = 48) or the DNG gro...
The VAS pain score was significantly decreased in both groups after 3 months of treatment. Three months later, patients receiving DNG reported significantly lower VAS scores compared with those treate...
Both DNG and LNG-IUS significantly improved adenomyosis-associated pain after 3 months of treatment. Compared with LNG-IUS, DNG was shown to continuously relieve the symptoms of pain and effectively c...
Levonorgestrel intrauterine systems (LNG-IUSs) are polydimethylsiloxane (PDMS) based non-biodegradable complex drug-device combination products providing efficacy for up to several years based on the ...
The commonly used combined hormonal contraceptives with progestins and ethinylestradiol are associated with an increased risk of ischemic stroke (IS). Progestin-only preparations, including levonorges...
In this Danish historical cohort study (2004-2021), we followed nonpregnant women (18-49 years) registering incident IS and ICH in relation to use of LG-IUDs/nonuse of hormonal contraceptives utilizin...
A total of 1 681 611 nonpregnant women contributed 11 971 745 person-years (py) of observation. Mean age at inclusion was 30.0 years; mean length of follow-up was 7.1 years; 2916 women (24.4 per 100 0...
The use of LG-IUD was associated with a 22% lower incidence rate of IS without raising the incidence rate of ICH. The finding raises the question of whether levonorgestrel, in addition to its contrace...
To evaluate heavy menstrual bleeding treatment outcomes with levonorgestrel 52-mg intrauterine device (IUD) use in participants without body mass index (BMI) or parity restrictions....
Investigators included participants aged 18-50 years with no pelvic or systemic pathology causing heavy menstrual bleeding at 29 U.S. centers in a prospective trial. Participants had up to three scree...
Of 105 enrolled participants, 47 (44.8%) had obesity (BMI 30.0 or higher) and 29 (27.6%) were nulliparous. Baseline mean blood loss ranged from 73 to 520 mL (median 143 mL, interquartile range 112-196...
This levonorgestrel 52-mg IUD reduces blood loss by more than 90% over 6 months compared with baseline for most users with heavy menstrual bleeding....
Medicines360....
ClinicalTrials.gov , NCT03642210....
To characterise patient satisfaction 6 and 12 months after insertion of a 52 mg levonorgestrel-releasing intrauterine system (LNG-IUS) in Portuguese women....
A non-interventional and prospective study was conducted in Portuguese women of reproductive age who had Levosert...
A total of 102 women were enrolled, of which only 94 (92.2%) completed the study. Seven participants discontinued the use of the 52 mg LNG-IUS. At 6 and 12 months, 90.7% and 90.4% of participants, res...
These data suggest that the continuation and satisfaction rates with Levosert...
Intrauterine devices (IUDs) are contraindicated in patients with known uterine anomalies, eliminating an extremely effective contraceptive option. However, data regarding contraceptive desires in thes...
A 20-year-old nulligravida with a uterus didelphys desired contraception after oral contraceptive pills and an etonogestrel implant failed. Despite extensive counseling, including Centers for Disease ...
In select patients with uterine anomalies, IUD placement can be a safe and effective option. This is especially important in adolescents who might be at increased risk for unintended pregnancy and poo...
The intention of this systematic review was to analyze the literature on breast cancer (BC) and the use of the levonorgestrel-releasing intrauterine system (LNG-IUS)....
The literature was searched in Medline, Embase, Cochrane Library, CINAHL, Web of Science and ClinicalTrials.com and included search terms related to breast cancer and LNG-IUS. After elimination of dup...
6 out of the 10 selected studies were cohort studies, three were case-control studies and one a systematic review/meta-analysis. 6 found a positive association between BC and the use of LNG-IUS. One s...
The results imply an increased BC risk in LNG-IUS users, especially in postmenopausal women and with longer duration of use. Positive effects of the LNG-IUS such as reduced risks for other hormonal ca...